MDM2 antagonists - a therapeutic approach for patients with hepatocellular carcinoma?

被引：0
|
作者：
Mahdi, A. [1 ]
Lunec, J. [1 ]
Reeves, H. [1 ,2 ]
机构：
[1] Newcastle Univ, NICR, Newcastle Upon Tyne, Tyne & Wear, England
[2] Newcastle Upon Tyne Hosp NHS Fdn Trust, Freeman Hosp, Liver Unit, Newcastle Upon Tyne, Tyne & Wear, England
来源：
EUROPEAN JOURNAL OF CANCER | 2016年 / 61卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
240
引用
收藏
页码：S44 / S44
页数：1
相关论文
共 50 条
  • [1] Analysis of immune landscape in hepatocellular carcinoma patients with MDM2/4 mutations
    Wang, Xinjun
    Zhang, Hushan
    Yang, Yuan
    Du, Hang
    Tang, Jingling
    CANCER RESEARCH, 2022, 82 (12)
  • [2] MDM2 gene amplification and protein expressions in colon carcinoma: is targeting MDM2 a new therapeutic option?
    Monirath Hav
    Louis Libbrecht
    Liesbeth Ferdinande
    Piet Pattyn
    Stephanie Laurent
    Marc Peeters
    Marleen Praet
    Patrick Pauwels
    Virchows Archiv, 2011, 458 : 197 - 203
  • [3] MDM2 gene amplification and protein expressions in colon carcinoma: is targeting MDM2 a new therapeutic option?
    Hav, Monirath
    Libbrecht, Louis
    Ferdinande, Liesbeth
    Pattyn, Piet
    Laurent, Stephanie
    Peeters, Marc
    Praet, Marleen
    Pauwels, Patrick
    VIRCHOWS ARCHIV, 2011, 458 (02) : 197 - 203
  • [4] Bilateral function of Mdm2 in the carcinogenesis and progression of hepatocellular carcinoma.
    Makino, Yuki
    Hikita, Hayato
    Kodama, Takahiro
    Kai, Yugo
    Nozaki, Yasutoshi
    Nakabori, Tasuku
    Saito, Yoshinobu
    Sakamori, Ryotaro
    Tatsumi, Tomohide
    Takehara, Tetsuo
    HEPATOLOGY, 2017, 66 : 981A - 981A
  • [5] TP 53 and MDM2 gene polymorphisms and risk of hepatocellular carcinoma among Italian patients
    Valeria Di Vuolo
    Luigi Buonaguro
    Francesco Izzo
    Simona Losito
    Gerardo Botti
    Franco M Buonaguro
    Maria Lina Tornesello
    Infectious Agents and Cancer, 6
  • [6] THERAPEUTIC MODULATION OF MDM2 IN NEUROBLASTOMA
    Kania, Katarzyna
    Pollok, Karen
    Gelbert, Larry
    Shannon, Harlan
    Bailey, Barbara
    Batuello, Christopher
    NEURO-ONCOLOGY, 2014, 16
  • [7] Protein expression of MDM2 and its clinicopathological relationships in human hepatocellular carcinoma
    Endo, K
    Ueda, T
    Ohta, T
    Terada, T
    LIVER, 2000, 20 (03): : 209 - 215
  • [8] TP53 and MDM2 gene polymorphisms and risk of hepatocellular carcinoma among Italian patients
    Di Vuolo, Valeria
    Buonaguro, Luigi
    Izzo, Francesco
    Losito, Simona
    Botti, Gerardo
    Buonaguro, Franco M.
    Tornesello, Maria Lina
    INFECTIOUS AGENTS AND CANCER, 2011, 6
  • [9] Functional association of MDM2 binding protein with metastatic potential of hepatocellular carcinoma
    Bi, Qian
    Tang, Shanhong
    Fan, Rui
    Agarwal, Neeraj
    Shi, Yongquan
    Iwakuma, Tomoo
    Ding, Jie
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2013, 28 : 609 - 610
  • [10] MDM2 as an independent prognostic marker in breast carcinoma patients
    Turbin, DA
    Cheang, MCU
    Gelmon, K
    Yorida, E
    Nielson, TO
    Gilks, CB
    Huntsman, DG
    MODERN PATHOLOGY, 2005, 18 : 53A - 53A
12345